StonvexLoading…
StonvexStonvexStonvexCore line items from SNGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 |
|---|---|---|---|---|
Revenue | $1.93M | $3.22M | $3.97M | $4.75M |
Operating Income | $-18.59M | $-10.54M | $-9.06M | $-7.59M |
Net Income | $-17.69M | $-9.36M | $-8.90M | $-7.15M |
EPS (Diluted) | $-0.64 | Not available | Not available | $-1.16 |
Total Assets | $19.89M | $7.78M | $10.49M | $9.55M |
Total Liabilities | $16.15M | $6.32M | $4.21M | Not available |
Cash & Equivalents | $18.68M | $5.42M | $8.98M | $7.81M |
Free Cash Flow OCF − CapEx | $-11.46M | $-7.54M | $-7.25M | $-6.54M |
Shares Outstanding | 30.64M | 21.75M | 17.68M | 8.73M |